A23V (p.Ala23Val) variant of SGCA (Alpha-sarcoglycan)

A23V (p.Ala23Val) in SGCA (Alpha-sarcoglycan) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.60 / 1. The record also includes population frequency data and structural context.

A23V (p.Ala23Val) variant details